Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07245784 · ClinicalTrials.gov registry record · NA

Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

A NA study of Cognitive Function, sponsored by Radicle Science.

Recruiting
Registry status
NA
Development phase
850
Enrollment target
1
Study location

NCT07245784 is a NA study of Cognitive Function that is actively recruiting participants, run by Radicle Science. The registered enrollment target is 850 participants, above the 455-participant average among 20 other Cognitive Function trials with a reported enrollment target (87% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07245784, a NA study of Cognitive Function, is actively recruiting participants, sponsored by Radicle Science.

RECRUITING
Registry status
NA
Development phase
850 participants
Enrollment target
1
Study location

Study Summary

A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Clarity Product Placebo Control
  • DIETARY_SUPPLEMENT Clarity Active Product 1

Study Locations (1)

California

  • Radicle Science Inc. - Del Mar

Trial Details

FieldValue
Enrollment Target 850 participants
Start Date 2025-12-04
Est. Completion 2026-12-04
Phase NA

Sponsor

Radicle Science

55 total trials

What the Registry Record Tells You About NCT07245784

The ClinicalTrials.gov registry entry for NCT07245784 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 455-participant average among 20 other Cognitive Function trials with a reported enrollment target (87% higher). The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cognitive Function appearing as the primary indexed condition, and to 2 interventions - of which Clarity Product Placebo Control is the first listed.

NCT07245784 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07245784 about?

NCT07245784 is a clinical study titled "Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes". A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

What is the current status of trial NCT07245784?

This trial is currently recruiting. It is a NA study. The enrollment target is 850 participants. The study started on 2025-12-04. Estimated completion is 2026-12-04.

What conditions does trial NCT07245784 study?

This clinical trial studies the following conditions: Cognitive Function.

What interventions are being tested in trial NCT07245784?

The interventions under investigation include: Clarity Product Placebo Control (DIETARY_SUPPLEMENT), Clarity Active Product 1 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07245784?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07245784 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.